The market of injectable drugs in India is on the rise with many factors contributing to the promising growth rate. This is because it is occasioned by new diseases, increasing cases of chronic diseases, increased population age, and the need to improve the treatment processes. The movement from disease orientation to biologics and targeted therapies as well as improvement in the drug delivery systems is transforming the injectables market in India. This growth is attributed to the improvement of the healthcare sector in India and the availability of the health facilities. With the... >>More
Dr. Shuchin Bajaj, Founder Director, Ujala Cygnus
Saransh Chaudhary, President, Global Critical Care, Venus Remedies
Venkatnarayanan K, Sr. Vice President and Head- Customer Services Zone India, Siemens Healthineers
Kshitij Rishi, Co-Founder & COO, 4basecare
Sourabh Tiwari, CIO, Meril Group of Companies